Quantinuum (NASDAQ:QNT) Shares Up 11.5% - Here's Why

Key Points

• Oracle partnership boosts commercial access: Quantinuum plans to deploy its 98-qubit Helios system in an Oracle Cloud Infrastructure data center, allowing customers to use quantum computing through the cloud without purchasing specialized hardware.
• Strong growth and analyst optimism lifted shares: Second-quarter revenue surged 279% year over year, and the company raised its fiscal 2026 revenue outlook to $28 million-$32 million. Shares rose 11.5%, while analysts maintained largely bullish ratings and a $98.42 consensus price target.
• Losses remain a key risk: Quantinuum reported an $0.28 quarterly loss per share, worse than the expected $0.26 loss, on $8 million in revenue. Continued losses and the early stage of quantum-computing commercialization could weigh on the investment case.

Quantinuum Inc. (NASDAQ:QNT - Get Free Report)'s share price rose 11.5% during mid-day trading on Wednesday . The stock traded as high as $62.74 and last traded at $62.49. 618,515 shares changed hands during trading, a decline of 76% from the average daily volume of 2,620,271 shares. The stock had previously closed at $56.06.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Oracle partnership expands commercial reach: Quantinuum will deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure data center. Making Helios available as an OCI service could give enterprise, artificial-intelligence, academic, and research customers access to quantum computing without buying specialized hardware. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: Rapid revenue growth and higher outlook: Second-quarter revenue rose 279% year over year, and management raised its fiscal 2026 revenue outlook to $28 million-$32 million, above the roughly $26.6 million consensus estimate. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Analysts remain optimistic: Rosenblatt reaffirmed a Buy rating with a $155 price target, while Needham maintained Buy at $100 and Cantor Fitzgerald reiterated Overweight at $90. These targets imply substantial potential upside from recent trading levels.
• Positive Sentiment: Technology milestone supports the investment case: Quantinuum reported near five-nines logical fidelity on Helios, reinforcing its positioning in fault-tolerant quantum computing and potentially improving its appeal to commercial users. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Neutral Sentiment: Short-interest data offers little signal: Reported short interest was zero shares, making the stated short-interest ratio uninformative rather than a meaningful indicator of investor positioning.
• Negative Sentiment: Quarterly loss exceeded expectations: Quantinuum reported a loss of $0.28 per share versus the consensus loss estimate of $0.26, while quarterly revenue was $8 million. Continued losses and the early stage of quantum-computing commercialization remain key risks. Quantinuum earnings results

Wall Street Analysts Forecast Growth

Several research firms have commented on QNT. Mizuho began coverage on shares of Quantinuum in a report on Monday, June 29th. They issued an "outperform" rating and a $90.00 price objective on the stock. TD Cowen initiated coverage on shares of Quantinuum in a report on Monday, June 29th. They set a "buy" rating for the company. Wall Street Zen downgraded shares of Quantinuum from a "hold" rating to a "sell" rating in a research report on Saturday, July 4th. Cantor Fitzgerald restated an "overweight" rating and set a $90.00 price objective on shares of Quantinuum in a report on Wednesday. Finally, Morgan Stanley assumed coverage on Quantinuum in a research note on Monday, June 29th. They issued an "equal weight" rating and a $78.00 price target for the company. Twelve analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $98.42.

Quantinuum Stock Performance

The company has a fifty day moving average of $62.71.

Quantinuum (NASDAQ:QNT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.02). The company had revenue of $8.00 million during the quarter. On average, equities analysts predict that Quantinuum Inc. will post -1.61 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Manish H. Bhatia bought 20,000 shares of the company's stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $60.00 per share, for a total transaction of $1,200,000.00. Following the transaction, the director owned 25,833 shares of the company's stock, valued at $1,549,980. This represents a 342.88% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kenneth D. Denman acquired 14,000 shares of the firm's stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $840,000.00. Following the completion of the purchase, the director directly owned 19,833 shares of the company's stock, valued at $1,189,980. The trade was a 240.01% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 411,032 shares of company stock valued at $24,661,920 over the last 90 days.

Hedge Funds Weigh In On Quantinuum

A hedge fund recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC bought a new position in shares of Quantinuum Inc. (NASDAQ:QNT - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,005 shares of the company's stock, valued at approximately $409,000.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source